MoneyWorks4Me

Alembic Pharmaceuticals board recommends Dividend

27 Apr 2015 Evaluate

Alembic Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on April 27, 2015, has recommended a dividend of Rs 3.50 (175%) per Equity Share of face value of Rs 2 each, subject to approval of Shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..